Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	48.22	-35.56	-68.67
Graham Fair Price	-50.16	1.90	3.81
PEG	13.59	0.39	-0.34
Price/Book	-37.49	7.48	11.96
Price/Cash Flow	-210187.29	-171599.00	-81.60
Prices/Earnings	-153.58	-29.16	-11.50
Price/Sales	-86.60	9437.94	70418.79
Price/FCF	-210187.29	-171599.00	-81.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	75.43	-83.05	-337.93
Operating Margin	79.59	-251.92	-1234.40
ROA	73.91	-0.03	-0.12
ROE	-0.26	-0.06	75.35
ROIC	-0.12	-0.12	-0.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	20.80	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.18	0.03	-84.36
EPS QOQ	0.34	0.76	123.23
FCF QOQ	-0.27	1.00	276.72
Revenue QOQ	1.00	3.76	276.19
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5.03	1.15	-77.13
Days Sales Outstanding (DSO)	90.00	0.45	-99.50
Inventory Turnover	17.88	78.18	337.18
Debt/Capitalization	0.44	0.41	-7.88
Quick Ratio	10.95	8.42	-23.14
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	1.57	1.58	0.39
Cash	2.60	2.32	-10.78
Capex	-0.08	0.00	inf
Free Cash Flow	-0.23	< 0.005	99.97
Revenue	< 0.005	< 0.005	368.21
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	11.07	8.52	-23.08
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.15	1.91	-54.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating